Ignite Creation Date:
2024-05-06 @ 2:29 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02059720
Status:
UNKNOWN
Last Update Posted:
2020-02-05
First Post:
2014-02-10
Brief Title:
Haplo-SCT vs ASCT With or Without Decitabine in AML CR1
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
The First Affiliated Hospital of Soochow University
Study Overview
Official Title:
Haplo-mismatch Donor Stem Cell Transplantation SCT Versus Autologous SCT Followed or Not by Maintenance Therapy for Patients With Acute Myeloid Leukemia AML in First Remission A Chinese Randomized Multicenter Study
Status:
UNKNOWN
Status Verified Date:
2020-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A multicentre prospective open-label clinical study including a randomized controlled study in low or intermediate-risk group patients and a cohort study of maintenance treatment with decitabine after ASCT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ChiCTR-TRC-14004196 | REGISTRY | Chinese Clinical Trial Registry ChiCTR | None |